SCHEMBL21149148

SCHEMBL21149148

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5cccc6sc7ccccc7c56)c4)nc(-c4ccc5c(c4)sc4ccccc45)n3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.39
ALDH1A1 P00352 4/20 0.37
MAPT P10636 4/20 0.37
HPGD P15428 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
RAB9A P51151 1/20 0.37
LIMK1 P53667 2/20 0.36
F9 P00740 1/20 0.36
GPR3 P46089 1/20 0.35
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
PIM3 Q86V86 1/20 0.33
PIK3CA P42336 1/20 0.33
PI4KA P42356 1/20 0.33
PI4KB Q9UBF8 1/20 0.33
MAP3K8 P41279 1/20 0.33
SLC9A1 P19634 1/20 0.33
KDM4E B2RXH2 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21148572 0.99 ALOX5 (0.38) ALOX5ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL22760349 0.99 ALOX5 (0.39) ALOX5ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL21149138 0.97 ALOX5 (0.39) ALOX5ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL22241003 0.97 ALOX5 (0.40) ALOX5ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL25851959 0.96 F9 (0.38) ALOX5ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL21148730 0.96 F9 (0.38) ALOX5ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL21148605 0.96 ALOX5 (0.39) ALOX5ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL21108832 0.96 F9 (0.39) ALOX5ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL21148597 0.96 F9 (0.39) ALOX5ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL21108835 0.95 F9 (0.39) ALOX5ALDH1A1MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 ALOX5 306/4885ALDH1A1 191/4885MAPT 1761/4885
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 ALOX5 306/4885ALDH1A1 191/4885MAPT 1761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.